文献速递心力衰竭与心肌病

全表观基因组关联研究揭示心脏基因模式与心力衰竭新型生物标志物

Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure.
PubMed 文献 · Circulation · 2017-08-24

该研究在扩张型心肌病患者的左心室活检和外周血中开展首次多组学表观基因组关联研究,筛选出59个与扩张型心肌病显著相关的表观遗传位点,其中3个达到全表观基因组显著性,并发现跨组织保守的DNA甲基化模式可作为心力衰竭的新型表观遗传生物标志物。

要点

  • 在心肌组织和外周血中鉴定出与扩张型心肌病相关的表观遗传位点。
  • 部分位点在不同队列中可重复,提示表观遗传调控心脏转录调节因子。
  • 跨组织保守的CpG甲基化模式可作为心力衰竭新型生物标志物。

核心结论

  • 首次在活体心力衰竭患者中开展全表观基因组关联研究,采用多组学方法。
  • 鉴定出与扩张型心肌病相关的表观遗传位点及跨组织保守的甲基化模式,可作为心力衰竭新型生物标志物。

研究设计与样本

  • 研究类型:多组学研究,包括全表观基因组关联研究。
  • 样本:扩张型心肌病患者与对照者的左心室活检组织和全外周血。
  • 方法:使用Infinium Human Methylation 450进行DNA甲基化高密度全表观基因组定位,并行RNA深度测序,全基因组测序排除基因型诱导的甲基化调用。

主要发现

  • 筛查阶段检测到59个与扩张型心肌病显著相关的表观遗传位点(错误发现校正P≤0.05),其中3个达到全表观基因组显著性(P≤5×10-8)。
  • 采用分阶段多组学设计,将517个表观遗传位点的子集与扩张型心肌病及心脏基因表达联系起来。
  • 鉴定出跨组织保守的独特表观遗传甲基化模式,使这些CpG成为心力衰竭的新型表观遗传生物标志物。

临床怎么用

  • 跨组织保守的CpG甲基化模式有潜力作为心力衰竭的表观遗传生物标志物。
  • 表观遗传位点可能有助于理解扩张型心肌病的心脏基因调控机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biochemical DNA modification resembles a crucial regulatory layer among genetic information, environmental factors, and the transcriptome. To identify epigenetic susceptibility regions and novel biomarkers linked to myocardial dysfunction and heart failure, we performed the first multi-omics study in myocardial tissue and blood of patients with dilated cardiomyopathy and controls. METHODS: Infinium human methylation 450 was used for high-density epigenome-wide mapping of DNA methylation in left-ventricular biopsies and whole peripheral blood of living probands. RNA deep sequencing was performed on the same samples in parallel. Whole-genome sequencing of all patients allowed exclusion of promiscuous genotype-induced methylation calls. RESULTS: In the screening stage, we detected 59 epigenetic loci that are significantly associated with dilated cardiomyopathy (false discovery corrected P≤0.05), with 3 of them reaching epigenome-wide significance at P≤5×10-8. Twenty-seven (46%) of these loci could be replicated in independent cohorts, underlining the role of epigenetic regulation of key cardiac transcription regulators. Using a staged multi-omics study design, we link a subset of 517 epigenetic loci with dilated cardiomyopathy and cardiac gene expression. Furthermore, we identified distinct epigenetic methylation patterns that are conserved across tissues, rendering these CpGs novel epigenetic biomarkers for heart failure. CONCLUSIONS: The present study provides to our knowledge the first epigenome-wide association study in living patients with heart failure using a multi-omics approach.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Meder B, Haas J, Sedaghat-Hamedani F, et al. Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure. Circulation. 2017. PMID: 28838933. doi:10.1161/CIRCULATIONAHA.117.027355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。